Jennifer Bergheiser

Mrs. Bergheiser is in charge of leading corporate strategy and all portfolio and commercial development efforts at eGenesis. Before eGenesis, Mrs. Bergheiser served as the Managing Principal for hatch health, where she consulted both private and public life science companies in the areas of new product planning, corporate strategy, business development and due diligence. Prior to hatch health, she served as the Managing Director for Genactis where she led and managed biotech clients on internal projects around new product and portfolio planning, and business development. Prior to Genactis, she was at Johnson & Johnson where she was responsible for key pre-launch activities spanning product development, market development, and lifecycle management for blockbuster injectable therapy (Stelara®). Prior to that, she worked in venture capital at Domain Associates.

Mrs. Bergheiser completed her Masters of Business Administration at The Wharton School of Business, and her B.A. in Economics and History at the University of Pennsylvania.